Biogen Idec should be split up, Icahn says
This article was originally published in Scrip
Executive Summary
Carl Icahn has called for Biogen Idec to be split into separate entities as he pursues his second proxy battle for the biotech firm in two years. The dissident shareholder argues that splitting the business in two would enhance shareholder value and attract buyers.